DecisionView announces Series D round investment
Printer Print Email Email
San Francisco: DecisionView, a provider of business performance optimization applications for the Life Sciences industry, has closed its Series D investment led by Granite Ventures, Adobe Ventures and Aeris Capital. Steve Andrade, CEO of DecisionView, said "Our venture capital partners' investment in DecisionView, especially during this dynamic global economic period, allows us to continue to remain acutely focused on our business strategy and deliver innovative solutions and value to the life sciences industry." The additional funding will be applied to DecisionView's strategic growth opportunities for expanding its distinctive platform for improving the performance of clinical trials. This includes the Company's flagship application, StudyOptimizer, the Web-based clinical trial enrollment software that enables companies to optimize the clinical trial recruitment and enrollment process for greater predictability, faster cycle times and reduced costs. Recently, DecisionView had announced several new features and enhancements to StudyOptimizer 4.0 including an innovative user interface framework, new analytic engine, an enterprise-class J2EE server and enhanced administration capabilities.

siliconindia